BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Saad RS, Silverman JF, Khalifa MA, Rowsell C. CDX2, cytokeratins 7 and 20 immunoreactivity in rectal adenocarcinoma. Appl Immunohistochem Mol Morphol. 2009;17:196-201. [PMID: 19098678 DOI: 10.1097/pai.0b013e31819268f2] [Cited by in Crossref: 36] [Cited by in F6Publishing: 41] [Article Influence: 2.6] [Reference Citation Analysis]
Number Citing Articles
1 Hrudka J, Matěj R, Nikov A, Tomyak I, Fišerová H, Jelínková K, Waldauf P. Loss of SATB2 expression correlates with cytokeratin 7 and PD-L1 tumor cell positivity and aggressiveness in colorectal cancer. Sci Rep 2022;12:19152. [PMID: 36351995 DOI: 10.1038/s41598-022-22685-0] [Reference Citation Analysis]
2 Malliou P, Syrnioti A, Koletsa T, Karlafti E, Karakatsanis A, Raptou G, Apostolidis S, Michalopoulos A, Paramythiotis D. Mucinous adenocarcinoma arising from a tailgut cyst: A case report. World J Clin Oncol 2022; 13(10): 853-860 [DOI: 10.5306/wjco.v13.i10.853] [Reference Citation Analysis]
3 Mun J, Hur W, Ku N. Roles of Keratins in Intestine. IJMS 2022;23:8051. [DOI: 10.3390/ijms23148051] [Reference Citation Analysis]
4 Dum D, Menz A, Völkel C, De Wispelaere N, Hinsch A, Gorbokon N, Lennartz M, Luebke AM, Hube-Magg C, Kluth M, Fraune C, Möller K, Bernreuther C, Lebok P, Clauditz TS, Jacobsen F, Sauter G, Uhlig R, Wilczak W, Steurer S, Minner S, Marx AH, Simon R, Burandt E, Krech T. Cytokeratin 7 and cytokeratin 20 expression in cancer: A tissue microarray study on 15,424 cancers. Exp Mol Pathol 2022;:104762. [PMID: 35390310 DOI: 10.1016/j.yexmp.2022.104762] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Hrudka J, Fišerová H, Jelínková K, Matěj R, Waldauf P. Cytokeratin 7 expression as a predictor of an unfavorable prognosis in colorectal carcinoma. Sci Rep 2021;11:17863. [PMID: 34504224 DOI: 10.1038/s41598-021-97480-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
6 Bellizzi AM. An Algorithmic Immunohistochemical Approach to Define Tumor Type and Assign Site of Origin. Adv Anat Pathol 2020;27:114-63. [PMID: 32205473 DOI: 10.1097/PAP.0000000000000256] [Cited by in Crossref: 27] [Cited by in F6Publishing: 30] [Article Influence: 9.0] [Reference Citation Analysis]
7 Taggart MW, Foo WC, Lee SM. Tumors of the Gastrointestinal System Including the Pancreas. Oncological Surgical Pathology 2020. [DOI: 10.1007/978-3-319-96681-6_12] [Reference Citation Analysis]
8 Wan KM, Foroughi F, Bansal R, Oehler MK. Intestinal Adenocarcinoma Arising from a Mature Cystic Teratoma. Case Rep Pathol 2019;2019:7894581. [PMID: 31827963 DOI: 10.1155/2019/7894581] [Reference Citation Analysis]
9 Al-Maghrabi J, Emam E, Gomaa W. Immunohistochemical staining of cytokeratin 20 and cytokeratin 7 in colorectal carcinomas: Four different immunostaining profiles. Saudi J Gastroenterol 2018;24:129-34. [PMID: 29637921 DOI: 10.4103/sjg.SJG_465_17] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
10 Geisinger KR, Spencer Raab S. Metastatic Tumors in the Lung. Practical Pulmonary Pathology: A Diagnostic Approach 2018. [DOI: 10.1016/b978-0-323-44284-8.00018-1] [Reference Citation Analysis]
11 Kotta DR, Somalwar SB, Challapudi S, Nagamuthu EA. CDX2 EXPRESSION IN GASTROINTESTINAL TUMOURS. jebmh 2017;4:4396-4400. [DOI: 10.18410/jebmh/2017/875] [Reference Citation Analysis]
12 Haraldsson S, Klarskov L, Nilbert M, Bernstein I, Bonde J, Holck S. Differential expression of CK20, β-catenin, and MUC2/5AC/6 in Lynch syndrome and familial colorectal cancer type X. BMC Clin Pathol 2017;17:11. [PMID: 28824332 DOI: 10.1186/s12907-017-0052-1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
13 Hewedi IH, Shakweer MM, Radwan NA. Diagnostic value of the combined use of SATB2 and CDX2 in mucinous carcinoma of colorectal origin. Egyptian Journal of Pathology 2017;37:112-119. [DOI: 10.1097/01.xej.0000516726.57921.51] [Reference Citation Analysis]
14 Bensaada FZ, Cadi HO, Sahraoui T, Kebir FZE. Colorectal Cancer: Epidemiological Study, Clinical, Histological and Immunohistochemistry Examination in Patient of West Algeria. JCT 2017;08:26-36. [DOI: 10.4236/jct.2017.81003] [Reference Citation Analysis]
15 Fusco N, Sciarra A, Guerini-Rocco E, Marchiò C, Vignani F, Colombo P, Ferrero S. Rediscovering Secondary Tumors of the Prostate in the Molecular Era. Adv Anat Pathol 2016;23:170-9. [PMID: 27058245 DOI: 10.1097/PAP.0000000000000115] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
16 Alkabie S, Bello B, Martinez RF, Geis WP, Ballo MS. Metastatic Adenocarcinoma of Unknown Origin Presenting as Small Bowel Perforation. Journal of Investigative Medicine High Impact Case Reports 2015;3:232470961557741. [DOI: 10.1177/2324709615577415] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
17 Benedeto-stojanov D, Bjelaković G, Milentijević M, Stojanov D, Brzački V, Petrović G. Metastatic lesions in the gastroduodenum — an unusual manifestation of malignant melanoma and pulmonary adenocarcinoma. Open Medicine 2014;9:762-7. [DOI: 10.2478/s11536-013-0321-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
18 Dragomir A, de Wit M, Johansson C, Uhlen M, Pontén F. The role of SATB2 as a diagnostic marker for tumors of colorectal origin: Results of a pathology-based clinical prospective study. Am J Clin Pathol 2014;141:630-8. [PMID: 24713733 DOI: 10.1309/AJCPWW2URZ9JKQJU] [Cited by in Crossref: 91] [Cited by in F6Publishing: 78] [Article Influence: 10.1] [Reference Citation Analysis]
19 Gurzu S, Szentirmay Z, Toth E, Bara T, Bara T, Jung I. Serrated pathway adenocarcinomas: molecular and immunohistochemical insights into their recognition. PLoS One. 2013;8:e57699. [PMID: 23469219 DOI: 10.1371/journal.pone.0057699] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
20 Bayrak R, Haltas H, Yenidunya S. The value of CDX2 and cytokeratins 7 and 20 expression in differentiating colorectal adenocarcinomas from extraintestinal gastrointestinal adenocarcinomas: cytokeratin 7-/20+ phenotype is more specific than CDX2 antibody. Diagn Pathol. 2012;7:9. [PMID: 22268990 DOI: 10.1186/1746-1596-7-9] [Cited by in Crossref: 116] [Cited by in F6Publishing: 122] [Article Influence: 10.5] [Reference Citation Analysis]
21 Saad RS, Silverman JF. Metastatic Tumors in the Breast. Breast Pathology 2012. [DOI: 10.1016/b978-1-4377-0604-8.00036-9] [Reference Citation Analysis]
22 Saad RS, Ghorab Z, Khalifa MA, Xu M. CDX2 as a marker for intestinal differentiation: Its utility and limitations. World J Gastrointest Surg 2011; 3(11): 159-166 [PMID: 22180832 DOI: 10.4240/wjgs.v3.i11.159] [Cited by in CrossRef: 59] [Cited by in F6Publishing: 63] [Article Influence: 4.9] [Reference Citation Analysis]
23 Lee PC, Lo C, Lin MT, Liang JT, Lin BR. Role of surgical intervention in managing gastrointestinal metastases from lung cancer. World J Gastroenterol 2011; 17(38): 4314-4320 [PMID: 22090788 DOI: 10.3748/wjg.v17.i38.4314] [Cited by in CrossRef: 49] [Cited by in F6Publishing: 56] [Article Influence: 4.1] [Reference Citation Analysis]
24 Raab SS, Allen TC, Leslie KO, Wick MR. Metastatic Tumors in the Lung. Practical Pulmonary Pathology: A Diagnostic Approach 2011. [DOI: 10.1016/b978-1-4160-5770-3.00031-6] [Reference Citation Analysis]
25 Shimizu M. Origin of Paget's cells in Paget's disease. Skin Cancer 2011;26:21-27. [DOI: 10.5227/skincancer.26.21] [Reference Citation Analysis]
26 Fritsch H, Zehm S, Illig R, Moser P, Aigner F. New insights into the development and differentiation of the human anorectal epithelia. Are there clinical consequences? Int J Colorectal Dis 2010;25:1231-42. [PMID: 20563874 DOI: 10.1007/s00384-010-0986-6] [Cited by in Crossref: 21] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
27 CDX2, Cytokeratins 7 and 20 Immunoreactivity in Rectal Adenocarcinoma: Erratum. Applied Immunohistochemistry & Molecular Morphology 2009;17:464. [DOI: 10.1097/pai.0b013e3181b8c211] [Reference Citation Analysis]
28 Saad RS, Ismiil N, Dubé V, Nofech-Mozes S, Khalifa MA. CDX-2 expression is a common event in primary intestinal-type endocervical adenocarcinoma. Am J Clin Pathol 2009;132:531-8. [PMID: 19762530 DOI: 10.1309/AJCP7E5ASGOENPFP] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
29 Tumors of the digestive system. Modern Immunohistochemistry 2000. [DOI: 10.1017/cbo9781316167366.006] [Reference Citation Analysis]